In vivo evidence that truncated trkB.T1 participates in nociception
<p>Abstract</p> <p>Brain-Derived Neurotrophic Factor (BDNF) is a central nervous system modulator of nociception. In animal models of chronic pain, BDNF exerts its effects on nociceptive processing by binding to the full-length receptor tropomyosin-related kinase B (trkB.FL) and tr...
Saved in:
Main Authors: | Leitch Carmen C (Author), Renn Cynthia L (Author), Dorsey Susan G (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2009-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Do Small Molecules Activate the TrkB Receptor in the Same Manner as BDNF? Limitations of Published TrkB Low Molecular Agonists and Screening for Novel TrkB Orthosteric Agonists
by: Piotr Pankiewicz, et al.
Published: (2021) -
IMMUNOHISTOCHEMICAL EXPRESSION OF NGF/TrkA AND BDNF/TrkB IN TUMOR PARIENCHYMA AND PERIPROSTATIC ADIPOSE TISSUE, DEPENDING ON THE PATHOANATOMIC STAGE OF PROSTATE CANCER
by: Nikolay Evtimov
Published: (2024) -
Brain-Derived Neurotrophic Factor/TrkB Signaling in Memory Processes
by: Kiyofumi Yamada, et al.
Published: (2003) -
Antitumor Activities and Cellular Changes Induced by TrkB Inhibition in Medulloblastoma
by: Amanda Thomaz, et al.
Published: (2019) -
Tropomyosin receptor kinase B (TrkB) signalling: targeted therapy in neurogenic tumours
by: Yuehua Li, et al.
Published: (2023)